Becton, Dickinson and Company (BMV:BDX)

Market Cap	1.02T -28.9%
Revenue (ttm)	394.70B +6.2%
Net Income	31.63B +1.7%
EPS	110.27 +3.1%
Shares Out	n/a
PE Ratio	32.10
Forward PE	16.42
Dividend	79.58 (2.25%)
Ex-Dividend Date	Dec 8, 2025

Volume	811
Average Volume	745
Open	3,535.21
Previous Close	3,353.59
Day's Range	3,535.21 - 3,535.21
52-Week Range	3,275.00 - 4,815.00
Beta	n/a
RSI	38.02
Earnings Date	Feb 9, 2026

About BMV:BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, va...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1897
• Employees: 72,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: BDX

Financial Performance

In fiscal year 2025, BMV:BDX's revenue was $21.84 billion, an increase of 8.24% compared to the previous year's $20.18 billion. Earnings were $1.68 billion, a decrease of -1.58%.

Financial numbers in USD